2YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
STAT6-IN-3 | 371919-80-1 | |
FTO-IN-1 TFA | 化合物 FTO-IN-1 TFA | 2797619-81-7 |
Bleximenib oxalate | (R)-N-乙基-5-氟-N-异丙基-2-((5-(2-(6-((2-甲氧基乙基)(甲基)氨基)-2-甲基己-3-基)-2,6-二氮杂螺[3.4]辛烷-6-基)-1,2,4-三嗪-6-基)氧基)苯甲酰胺 草酸盐 | 2866179-95-3 |
BMS-986365 | 化合物 BMS-986365 | 2446928-30-7 |
UH15-38 | 3-(3-羟基苯基)-1-甲基-7-((3-(4-甲基哌嗪-1-基)苯基)氨基)-1,6-萘啶-2(1H)-酮 | 2540881-21-6 |
Pyridine, 4-cyclohexyl-2,6-dimethyl- | PYRIDINE, 4-CYCLOHEXYL-2,6-DIMETHYL- | 1926949-71-4 |
(S)-2-((S)-2-((2S,3R)-2-((3R,8R,11R,14S,17S,20S,23S,29aS)-8-Acetamido-23-(benzo[b]thiophen-3-ylmethyl)-11,14,17-tris(3-guanidinopropyl)-4,4-dimethyl-20-(naphthalen-2-ylmethyl)-1,9,12,15,18,21,24-heptaoxohexacosahydro-2H-pyrido[2,1-g][1,2]dithia[5,8,11,14,17,20,23]heptaazacyclohexacosine-3-carboxamido)-3-hydroxybutanamido)-5-guanidinopentanamido)-3,3-dimethylbutanoic acid | 606226 | 2717490-36-1 |
4-Di-1-ASP | 4-(4-(DIMETHYLAMINO)STYRYL)-N-METHYLPYRIDINIUM IODIDE | 959-81-9 |
GDC-0339 | 1428569-85-0 | 1428569-85-0 |
GlyRS-IN-1 | 112921-11-6 | 112921-11-6 |
RO7185876 | (S)-N-[(1R,5S,8S)-3-(6-甲基-4-嘧啶基)-3-氮杂双环[3.2.1]辛烷-8-基]-9-(2,3,4-三氟苯基)-6,7,8,9-四氢-5H-[1,2,4]三唑并[1,5-A]氮杂卓-2-胺 | 2226038-71-5 |
cis-trismethoxy Resveratrol | 顺式白藜芦醇三甲醚 | 94608-23-8 |
MLN4924 hydrochloride | 氨基磺酸 [(1S,2S,4R)-4-[4-[[(1S)-2,3-二氢-1H-茚-1-基]氨基]-7H-吡咯并[2,3-D]嘧啶-7-基]-2-羟基环戊基]甲基酯盐酸盐 | 1160295-21-5 |
Leukotriene D4 | LEUKOTRIENE D4 | 73836-78-9 |
PF-06648671 | PF-06648671 | 1587727-31-8 |
EIPA | 5-(N-乙基-N-异丙基)阿米洛利 | 1154-25-2 |
Sclerotiorin | 核丛青霉素 | 549-23-5 |
AZ12672857 | 化合物AZ12672857 | 945396-55-4 |
Zuclopenthixol | 珠氯噻醇 | 53772-83-1 |
5-Bromo-3-(3-((tert-butyldiphenylsilyl)oxy)-2,2-dimethylpropyl)-2-iodo-1H-indole | 5-溴-3-(3-((叔丁基二苯基甲硅烷基)氧基)-2,2-二甲基丙基)-2-碘-1H-吲哚 | 2641451-43-4 |
PI3K/Akt/mTOR-IN-2 | 化合物 PI3K/AKT/MTOR-IN-2 | 2757804-89-8 |
IRE1α kinase-IN-5 | 2771006-47-2 | |
Benzenesulfonic acid, 2-hydroxy-3-methoxy-, potassium salt (1:1) | 859188-04-8 | |
Thalidomide-5-NH-PEG1-NH2 hydrochloride | 2863634-98-2 | |
Tetrahydrocorticosterone | 四氢皮质酮 | 68-42-8 |
A-967079 | (1E,3E)-1-(4-氟苯基)-2-甲基-1-戊烯-3-酮肟 | 1170613-55-4 |
Mutant IDH1-IN-2 | Mutant IDH1-IN-2 | 1429176-69-1 |
ADENYLOSUCCINIC ACID | 腺苷酸基琥珀酸 | 19046-78-7 |
GSK2850163 | 2121989-91-9 | 2121989-91-9 |
Etomoxir | 乙莫克舍 | 124083-20-1 |
Lenalidomide-C5-NH2 | E3 Ligand-Linker Conjugate 4 | 2093388-45-3 |
ZM 449829 | 2-萘乙烯基酮 | 4452-06-6 |
2-(4-Chloro-3,5-dimethylphenoxy)acetic acid | 4-氯-3,5-二甲苯氧基乙酸 | 19545-95-0 |
Trimetrexate | 三甲曲沙 | 52128-35-5 |
STAT6-IN-2 | (R)-4-(1-甲基-1H-吲哚-2-基)-N2-(3-甲基丁-2-基)-N6-(2-(吡啶-2-基)乙基)吡啶-2,6-二甲酰胺 | 1355594-85-2 |
Propanoic acid, 3-[(aminocarbonyl)amino]-2-methyl-, sodium salt (1:1) | 84796-57-6 | |
Olcegepant/BIBN-4096/BIBN 4096BS | N-[2-[5-氨基-1(S)-[4-(4-吡啶基)哌嗪-1-甲酰基]戊基氨基]-1(R)-(3,5-二溴-4-羟基苄基)-2-氧代乙基]-4-(2-氧代-1,2,3,4-四氢喹唑啉-3-基)哌啶-1-甲酰胺 | 204697-65-4 |
benzyl (S)-4-(5-(5-bromo-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-1H-indol-2-yl)-6-(1-methoxyethyl)pyridin-3-yl)piperazine-1-carboxylate | (S)-4-(5-(5-溴-1-乙基-3-(3-羟基-2,2-二甲基丙基)-1H-吲哚-2-基)-6-(1-甲氧基乙基)吡啶-3-基)哌嗪-1-羧酸苄酯 | 2865162-09-8 |
MZ-101/GYS1-IN-2 | 2839908-40-4 | |
VH032-C7-amine hydrochloride | 2502189-41-3 | |
Methanol, 1-(diethylamino)-, hydrochloride (1:1) | 2227608-08-2 | |
NMS-E973 | NMS-E973 | 1253584-84-7 |
HS148 | HS148 | 1892595-16-2 |
10,11-Dehydrocurvularin | ALPHA,BETA-DEHYDROCURVULARIN | 21178-57-4 |
Velagliflozin | Velagliflozin | 946525-65-1 |
Spirapril Hydrochloride | 盐酸螺普利 | 94841-17-5 |
benzyl 4-[5-bromo-6-[(1S)-1-methoxyethyl]-3-pyridyl]piperazine-1-carboxylate | (S)-1-[5-溴-6-(1-甲氧基乙基)-3-吡啶基]-4-CBZ-哌嗪 | 2641451-78-5 |
KIN-3248 | RESIGRATINIB | 2750709-91-0 |
(2S,4S)-4-Acetoxy-3,4-dihydro-2H-pyran-2-yl]methyl Acetate | 乙酸[[(2S,4S)-4-乙酰氧基-3,4-二氢-2H-吡喃-2-基]甲基]酯 | 13036-11-8 |
BRACO19 trihydrochloride | BRACO 19 | 351351-75-2 |
1,4,5,6-Tetrahydro-1-phenyl-3-cyclopentapyrazoleacetic acid | 21484-52-6 | |
CCT241533 hydrochloride | CCT 241533 盐酸盐 | 1431697-96-9 |
Rp-cAMPS sodium salt | ADENOSINE-3',5'-CYCLIC MONOPHOSPHOROTHIOATE, RP-ISOMER SODIUM SALT | 142439-94-9 |
QCA570 | QCA570 | 2207569-08-0 |
MI-1061 | MI-1061 | 1410737-34-6 |
RGD Trifluoroacetate | (S)-2-(2-((S)-2-氨基-5-胍基戊酰胺基)乙酰氨基)琥珀酸三氟乙酸盐 | 2378808-45-6 |
Sorivudine | 索立夫定 | 77181-69-2 |
1,1,2,2-Tetramethoxyethane | 1,1,2,2- 四甲氧基乙烷 | 2517-44-4 |
lactoyl-CoA | L-乳酰辅酶A | 1926-57-4 |
Diaporthein B | 577705-64-7 | |
ML334 | ML334 | 1432500-66-7 |
Tedatioxetine hydrobromide | 960151-65-9 | 960151-65-9 |
AVN492 | CS-2812 | 1220646-23-0 |
Minnelide sodium | 1254702-87-8 | 1254702-87-8 |
Porphobilinogen | 紫質膽素原 | 487-90-1 |
KTX-582 | 2573298-13-0 | |
ARV393 | ARV-393 | 2851885-95-3 |
BBO-8520 | BBO-8520, KRAS G12C 抑制剂 | 2893809-51-1 |
(2R,4S,E)-4-(2-(3,4-Dihydroxyphenethoxy)-2-oxoethyl)-3-ethylidene-2-hydroxy-3,4-dihydro-2H-pyran-5-carboxylic acid | 113145-68-9 | |
NA | 2607830-80-6 | |
Cytochalasin C | 细胞松驰素 C | 22144-76-9 |
SMER18 | CS-2054 | 944153-47-3 |
Sibirioside A | 斩龙剑苷A | 173046-19-0 |
GlcNAcstatin | GlcNAcstatin | 922163-64-2 |
5-(N,N-Dimethyl)amiloride hydrochloride | 3-氨基-N-(氨基亚氨基乙基)-5-(二甲氨基)-6-氯吡嗪甲酰胺 盐酸盐 | 1214-79-5 |
Misetionamide/GP-2250 | 1,4,3-氧杂噻嗪 4,4-二氧化物 | 856785-75-6 |
Piliformic acid | 98985-76-3 | |
CP 96021 | 化合物CP 96021 | 139401-43-7 |
RLY-4008 | 化合物FGFR2-IN-3 | 2549174-42-5 |
Bleximenib/Menin-MLL inhibitor 24 | 2654081-35-1 | |
CK1α degrader-1 | 2881012-96-8 | |
2-Chloro-4-methyl-5-(trifluoromethyl)pyridine | 2-氯-4-甲基-5-三氟甲基吡啶 | 780802-36-0 |
CDK4/6-IN-2 | CDK4/6-IN-2 | 1800506-48-2 |
NLRP3-IN-19 | 化合物 NLRP3-IN-19 | 2238819-65-1 |
benzyl (S)-4-(6-(1-methoxyethyl)-5-(4,4,5,5-tetram | (S)-5-(4-CBZ-1-哌嗪基)-2-(1-甲氧基乙基)吡啶-3-硼酸频哪醇酯 | 2641451-79-6 |
Cycloaspeptide A | Cycloaspeptide A | 109171-13-3 |
Diphenidol | 地芬尼多 | 972-02-1 |
Luteoskyrin | Rugulosin, 8,8'-dihydroxy-, (1S,1'S,2R,2'R,3S,3'S,9aR,9'aR)- | 21884-44-6 |
PF-07208254 | 2573122-40-2 | |
BRD0639 | 化合物 BRD0639 | 2760881-74-9 |
Thalidomide-5-NH-PEG3-NH2 hydrochloride | 2863635-01-0 | |
Taltobulin intermediate-4 | (S,E) - 4 - ((S)-2 - ((叔丁氧基羰基)氨基)-N,3,3-三甲基丁酰胺基)-2 | 187345-37-5 |
BRD-6929 | BRD 6929;COMPOUND-60 | 849234-64-6 |
CI13015 | 偶氮间苯二酚磺酸钠) | 2706-28-7 |
PF-06700841-TsOH | CS-2860 | 2140301-96-6 |
ACHN-975 TFA | (2S)-3-amino-N-hydroxy-2-[(4-{4-[(1R,2R)-2-(hydroxymethyl)cyclopropyl]buta-1,3-diyn-1-yl}phenyl)formamido]-3-methylbutanamide: trifluoroacetic acid | 1410809-37-8 |
ALX-1393 | 化合物 T14198 | 949164-09-4 |
CDK4/6-IN-15 | 化合物 CDK4/6-IN-15 | 2078047-99-9 |
4'-CHLOROPROPIOPHENONE | 4-氯苯丙酮 | 6285-05-8 |
AMG-0347 | 化合物 T29968 | 946615-43-6 |
联系方式